Related references
Note: Only part of the references are listed.Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer
Andrew Wilber et al.
BLOOD (2011)
Heterozygous disruption of human SOX6 is insufficient to impair erythropoiesis or silencing of fetal hemoglobin
Vijay G. Sankaran et al.
BLOOD (2011)
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Andrew Wilber et al.
BLOOD (2011)
A transient definitive erythroid lineage with unique regulation of the β-globin locus in the mammalian embryo
Kathleen E. McGrath et al.
BLOOD (2011)
siDNMT1 increases gamma-globin expression in chemical inducer of dimerization (CID)-dependent mouse beta YAC bone marrow cells and in baboon erythroid progenitor cell cultures
Virryan Banzon et al.
EXPERIMENTAL HEMATOLOGY (2011)
Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin
Stefania Satta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13
Vijay G. Sankaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Dominant Mutation in the Gene Encoding the Erythroid Transcription Factor KLF1 Causes a Congenital Dyserythropoietic Anemia
Lionel Arnaud et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Fetal globin expression is regulated by Friend of Prmt1
Thamar Bryn van Dijk et al.
BLOOD (2010)
A complex task? Direct modulation of transcription factors with small molecules
Angela N. Koehler
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6
Jian Xu et al.
GENES & DEVELOPMENT (2010)
Pharmacologic Induction of Fetal Hemoglobin Production
George Atweh et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Thalassemia: An Overview of 50 Years of Clinical Research
Vijay G. Sankaran et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Iron Overload in Thalassemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies
John B. Porter et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
Manit Nuinoon et al.
HUMAN GENETICS (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin
Joseph Borg et al.
NATURE GENETICS (2010)
KLF1 regulates BCL11A expression and γ- to β-globin gene switching
Dewang Zhou et al.
NATURE GENETICS (2010)
Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation
Genevieve Galarneau et al.
NATURE GENETICS (2010)
Reversing the Hemoglobin Switch.
Vijay G. Sankaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
James E. Bradner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells
Huiwu Zhao et al.
BLOOD (2009)
Amelioration of Sardinian β0 thalassemia by genetic modifiers
Renzo Galanello et al.
BLOOD (2009)
The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells
Karin Wahlberg et al.
BLOOD (2009)
Developmental and species-divergent globin switching are driven by BCL11A
Vijay G. Sankaran et al.
NATURE (2009)
Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease.
Matthew M. Hsieh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Recent Advances in Bone Marrow Transplantation in Hemoglobinopathies
Jennifer G. Michlitsch et al.
CURRENT MOLECULAR MEDICINE (2008)
Hydroxyurea for the treatment of sickle cell anemia
Orah S. Platt
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
Guillaume Lettre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin
Hassana Fathallah et al.
BLOOD (2007)
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Stephan Menzel et al.
NATURE GENETICS (2007)
Sox6 cell-autonomously stimulates erythroid cell survival, proliferation, and terminal maturation and is thereby an important enhancer of definitive erythropoiesis during mouse development
Bogdan Dumitriu et al.
BLOOD (2006)
cMYB is involved in the regulation of fetal hemoglobin production in adults
Jie Jiang et al.
BLOOD (2006)
Haemoglobin E β thalassaemia in Sri Lanka
A Premawardhena et al.
LANCET (2005)
Suppressor screen in Mpl-/- mice:: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling
MR Carpinelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Induction of human γ globin gene expression by histone deacetylase inhibitors
H Cao et al.
BLOOD (2004)
Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias
DJ Weatherall
NATURE REVIEWS GENETICS (2001)
Share Paper
